-
LABP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Landos Biopharma (LABP)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 29.05 mm | 29.05 mm | 29.05 mm | 29.05 mm | 29.05 mm | 29.05 mm |
Cash burn (monthly) | 2.83 mm | 1.35 mm | 3.10 mm | 2.18 mm | 2.83 mm | 1.73 mm |
Cash used (since last report) | 31.32 mm | 14.92 mm | 34.27 mm | 24.16 mm | 31.34 mm | 19.18 mm |
Cash remaining | -2.27 mm | 14.13 mm | -5.22 mm | 4.90 mm | -2.28 mm | 9.87 mm |
Runway (months of cash) | -0.8 | 10.5 | -1.7 | 2.2 | -0.8 | 5.7 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 15 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 8.77 mm |
Total shares | 2.14 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Osage University GP III | 1.83 mm | $8.77 mm |
Xontogeny | 309.09 k | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 May 24 | Fred Callori | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.1 | 1,800 | 16.38 k | 0 |
23 May 24 | Fred Callori | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.4 | 1,800 | 11.52 k | 0 |
23 May 24 | Fred Callori | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.3 | 1,800 | 5.94 k | 0 |
23 May 24 | Tiago Girao | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.1 | 1,800 | 16.38 k | 0 |
23 May 24 | Tiago Girao | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.4 | 1,800 | 11.52 k | 0 |
23 May 24 | Tiago Girao | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.3 | 1,800 | 5.94 k | 0 |
23 May 24 | Timothy M Mayleben | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.9 | 1,800 | 14.22 k | 0 |
23 May 24 | Timothy M Mayleben | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.3 | 1,800 | 5.94 k | 0 |
23 May 24 | Fabio Cataldi | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.9 | 39,999 | 355.99 k | 0 |
23 May 24 | Fabio Cataldi | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.7 | 18,449 | 68.26 k | 0 |